Walgreens recalled 41,328 bottles of Saline Nasal Spray on November 12, 2025. The recall follows a discovery of microbial contamination by pseudomonas lactis. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Microbial contamination of a non-sterile product - microorganism found to be pseudomonas lactis
Consumers and healthcare providers should stop using this product immediately. Contact Medical Products Laboratories, Inc. or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled product is Walgreens Saline Nasal Spray with Xylitol, packaged in 1.5 oz (45mL) bottles. The affected lot numbers include 71409 and 71861, with expiration dates of February 28, 2027, and August 31, 2027, respectively. It was distributed nationwide in the USA.
The nasal spray is contaminated with pseudomonas lactis, a microorganism that poses health risks, particularly for individuals with weakened immune systems. The contamination makes the product non-sterile, increasing the potential for infection.
There have been no reported injuries or illnesses linked to this recall. The high hazard level indicates a serious risk, particularly for susceptible individuals.
Consumers should stop using the affected nasal spray immediately. Contact Medical Products Laboratories, Inc. or consult a healthcare provider for further guidance. A notification letter will be sent to affected consumers.
For questions, consumers can contact Medical Products Laboratories, Inc. at their customer service line or visit the FDA recall page for more details.
Get instant alerts for recalls that affect you. Free forever.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,057 bags of Acyclovir Sodium Injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers should cease use immediately and contact the manufacturer for guidance.
Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,410 bags of ketamine HCl injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers and consumers must stop using this product immediately.
Fresenius Kabi Compounding recalled 10,548 bags of thiamine HCl injection on February 5, 2026. The recall follows a lack of assurance of sterility, posing a high health risk. Affected products include several lots expiring between February and May 2026.
Pro Numb Tattoo Numbing Spray was recalled due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers should stop using the spray immediately and contact Pro Numb Tattoo Numbing Spray LLC for guidance.
Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.